Skip to main content
. 2017 Feb 20;8(2):377–384. doi: 10.1007/s13300-017-0234-y

Fig. 1.

Fig. 1

Glucose control (a), body weight (b), insulin dose (c), and blood pressure (d) before and after switching to IDegLira in 55 Swiss patients who completed follow-up. Red dotted line in a shows normal value for HbA1c (5.5%). HbA 1c glycated hemoglobin, IDegLira insulin degludec/liraglutide, Δ mean change from baseline